Prostate-Specific Antigen in Female Serum, a Potential New Marker of Androgen Excess
Dimitrios N. Melegos,
He Yu,
Mala Ashok,
Chun Wang,
Frank Stanczyk and
Eleftherios P. Diamandis
Department of Pathology and Laboratory Medicine (D.N.M., H.Y.,
E.P.D.), Mount Sinai Hospital, Toronto, Ontario M5G 1X5; Department of
Clinical Biochemistry (D.N.M., H.Y., E.P.D.), University of Toronto,
Toronto, Ontario M5G 1L5, Canada; and Department of Obstetrics and
Gynecology (M.A., C.W., F.S.), Division of Reproductive Endocrinology
and Infertility, University of Southern California School of Medicine,
Los Angeles, California 90033
Address correspondence and requests for reprints to: Dr. E. P. Diamandis, Department of Pathology and Laboratory Medicine, 600 University Avenue, Toronto, Ontario, Canada, M5G 1X5.
Prostate-specific antigen (PSA) is present at very low concentrations
infemale serum, but it can now be measured with highly sensitive
immunoassays.We have found that in female tissues the PSA gene is
regulatedby steroid hormones through the action of steroid hormone
receptors.Thus, we examined whether female serum PSA is associated
withhyperandrogenic states. Serum PSA levels were compared between22
hirsute women with a Ferriman-Gallwey score higher than 8and 50 women
without hirsutism. The results show that PSA levelswere higher in
hirsute women in comparison with controls. Inhirsute women, levels of
PSA and 3-androstanediol glucuronide(3-AG), a specific
metabolite of androgen action, showed a significantpositive
correlation, whereas PSA and 3-AG showed a significantnegative
correlation with patient age. Receiver operating characteristic(ROC)
analysis revealed that 3-AG was a slightly better markerof androgen
excess than PSA. We conclude that female serum PSAmay be a new
biochemical marker of androgen action in females.
This article has been cited by other articles:
M. H. Slagter, A. Scorilas, L. J.G. Gooren, W. de Ronde, A. Soosaipillai, E. J. Giltay, M. Paliouras, and E. P. Diamandis Effect of Testosterone Administration on Serum and Urine Kallikrein Concentrations in Female-to-Male Transsexuals
Clin. Chem.,
August 1, 2006;
52(8):
1546 - 1551.
[Abstract][Full Text][PDF]
H. Aksoy, F. Akcay, Z. Umudum, A. K. Yildirim, and R. Memisogullari Changes of PSA Concentrations in Serum and Saliva of Healthy Women during the Menstrual Cycle
Ann. Clin. Lab. Sci.,
January 1, 2002;
32(1):
31 - 36.
[Abstract][Full Text][PDF]
C. V. Obiezu, A. Scorilas, A. Magklara, M. H. Thornton, C. Y. Wang, F. Z. Stanczyk, and E. P. Diamandis Prostate-Specific Antigen and Human Glandular Kallikrein 2 Are Markedly Elevated in Urine of Patients with Polycystic Ovary Syndrome
J. Clin. Endocrinol. Metab.,
April 1, 2001;
86(4):
1558 - 1561.
[Abstract][Full Text]
H. F. Escobar-Morreale, S. Ávila, and J. Sancho Serum Prostate-Specific Antigen Concentrations Are Not Useful for Monitoring the Treatment of Hirsutism with Oral Contraceptive Pills
J. Clin. Endocrinol. Metab.,
July 1, 2000;
85(7):
2488 - 2492.
[Abstract][Full Text]
C. V. Obiezu, E. J. Giltay, A. Magklara, A. Scorilas, L. J.G. Gooren, H. Yu, D. J.C. Howarth, and E. P. Diamandis Serum and Urinary Prostate-specific Antigen and Urinary Human Glandular Kallikrein Concentrations Are Significantly Increased after Testosterone Administration in Female-to-Male Transsexuals
Clin. Chem.,
June 1, 2000;
46(6):
859 - 862.
[Abstract][Full Text][PDF]
C. Negri, F. Tosi, R. Dorizzi, A. Fortunato, G. G. Spiazzi, M. Muggeo, R. Castello, and P. Moghetti Antiandrogen Drugs Lower Serum Prostate-Specific Antigen (PSA) Levels in Hirsute Subjects: Evidence That Serum PSA Is a Marker of Androgen Action in Women
J. Clin. Endocrinol. Metab.,
January 1, 2000;
85(1):
81 - 84.
[Abstract][Full Text]
V. H. H. Goh Breast Tissues in Transsexual Women-A Nonprostatic Source of Androgen Up-Regulated Production of Prostate-Specific Antigen
J. Clin. Endocrinol. Metab.,
September 1, 1999;
84(9):
3313 - 3315.
[Abstract][Full Text]
C. Lopez-Otin and E. P. Diamandis Breast and Prostate Cancer: An Analysis of Common Epidemiological, Genetic, and Biochemical Features
Endocr. Rev.,
August 1, 1998;
19(4):
365 - 396.
[Abstract][Full Text][PDF]
H. F. Escobar-Morreale, J. Serrano-Gotarredona, S. Avila, J. Villar-Palasí, C. Varela, and J. Sancho The Increased Circulating Prostate-Specific Antigen Concentrations in Women with Hirsutism Do Not Respond to Acute Changes in Adrenal or Ovarian Function
J. Clin. Endocrinol. Metab.,
July 1, 1998;
83(7):
2580 - 2584.
[Abstract][Full Text]
D. N. Melegos and E. P. Diamandis Is Prostate-Specific Antigen Present in Female Serum?
Clin. Chem.,
March 1, 1998;
44(3):
691 - 692.
[Full Text][PDF]
G. M. Lambert-Messerlian, J. A. Canick, D. N. Melegos, and E. P. Diamandis Increased concentrations of prostate-specific antigen in maternal serum from pregnancies affected by fetal Down syndrome
Clin. Chem.,
February 1, 1998;
44(2):
205 - 208.
[Abstract][Full Text][PDF]